Our work indicates that disruption of the vicious circle involving STAT3 signaling in the tumor microenvironment, along with the stimulation of TLR7/8 signaling, could induce effective antitumor immune responses without toxicity and chemotherapy-associated side effects. The gene discussed is TLR7; the disease is neoplasm.